| Randomized crossover trial comparing memantine or amantadine for Parkinson's disease with motor fluctuations in Juntendo | Randomized crossover trial comparing memantine or amantadine for Parkinson's disease with motor fluctuations in Juntendo - MAP-J | JPRN-UMIN000010596 |
| The effect of amantadine and Q10 in fatigue of the Multiple Sclerosis patients | Comparison of the effect of amantadine and coenzymeQ10 on the fatigue of the Multiple Sclerosis patients | IRCT2013092814792N1 |
| Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness | Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness | NCT02025439 |
| ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) | Efficacy and Safety of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia in Parkinson's Disease Patients (EASE LID Study) | NCT02136914 |
| Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID | A Multicenter, Randomized, Placebo-controlled, Double-blind, 26 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias | NCT02153632 |
| Amantadine to Speed Awakening After Cardiac Arrest | Amantadine to Speed Awakening After Cardiac Arrest | NCT02486211 |
| Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia | The Effect of Amantadine on Movement Disorder in Ataxia-Telangiectasia | NCT00950196 |
| Open-Label Safety Study of ADS-5102 in PD Patients With LID | Open-Label Safety Study of ADS-5102 (Amantadine HCl) Extended Release Capsules for the Treatment of Levodopa Induced Dyskinesia (LID) | NCT02202551 |
| A 26 Week Clinical Study to Evaluate the Use of Long-Acting Amantadine to Treat Parkinson's Disease Patients with Abnormal Involuntary Movements caused by Levodopa | A Multicenter, Randomized, Placebo-controlled, Double-blind, 26 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects with Levodopa-Induced Dyskinesias | EUCTR2014-001132-10-ES |
| A 16 Week Clinical Study to Evaluate the Use of Long-Acting Amantadine to Treat Parkinson's Disease Patients with Abnormal Involuntary Movements caused by Levodopa | A Multicenter, Randomized, Placebo-controlled, Double-blind, 16 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects with Levodopa-Induced Dyskinesias | EUCTR2014-001131-36-ES |
| Efficacy of amantadine in acquired brain injury. | Efficacy of amantadine on behavioural and emotional problems and impairment of executive functioning due to acquired brain injury to the frontal lobes: a series of single case experimental design studies. | EUCTR2012-005723-33-NL |
| Comparing the efficacy of bupropion and amantadine on sexual dysfunction induced by a selective serotonin reuptake inhibitor | Comparing the efficacy of bupropion and amantadine on sexual dysfunction induced by a selective serotonin reuptake inhibitor | IRCT201409275280N17 |
| Effect of Amantadine Administration on Spatial Functioning Following Traumatic Brain Injury | Effect of Amantadine Administration on Spatial Functioning Following Traumatic Brain Injury | NCT02321761 |
| A Randomized Open Label Study Comparing the Safety, Tolerability and Pharmacokinetics (PK) of Amantadine Hydrochloride and Ribavirin with Oseltamivir Phosphate (TCAD) Administered Orally Versus Oseltamivir alone Administered Orally to Influenza A Virus Infected Hospitalized Immunocompromised Patients | A Randomized Open Label Study Comparing the Safety, Tolerability and Pharmacokinetics (PK) of Amantadine Hydrochloride and Ribavirin with Oseltamivir Phosphate (TCAD) Administered Orally Versus Oseltamivir alone Administered Orally to Influenza A Virus Infected Hospitalized Immunocompromised Patients - TOMI trial: Triple Or Monotherapy in Influenza | NL-OMON32938 |
| An investigation of the clinical efficacy of amantadine on depressive syptoms and cognitive deficits in Borna Disease Virus (BDV) infected patients with an affective psychosis; a prospective, randomized, double-blind, placebo controlled, monocentric study. | An investigation of the clinical efficacy of amantadine on depressive syptoms and cognitive deficits in Borna Disease Virus (BDV) infected patients with an affective psychosis; a prospective, randomized, double-blind, placebo controlled, monocentric study. | DRKS00007649 |
| Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. | A Multicenter, Randomized, Placebo-controlled, Double-blind, 16 Week Study to Evaluate the Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias | NCT02153645 |
| post operative pain control | Preoperative single dose of oral Amantadine for acute and chronic post operative pain control in Mandibular fracture | IRCT201406201772N13 |
| The effects of a combination therapy of clonidine with dextromethorphan and/or amantadine on opium withdrawal syndrome compared with the single therapy of clonidine | Study of the effects of a combination therapy of clonidine with dextromethorphan and/or amantadine on opium withdrawal syndrome compared with the single therapy of clonidine | IRCT201207196972N2 |
| Clinical trial of Amantadine HCl for hypoxic encephalopathy | Clinical trial of Amantadine HCl for hypoxic encephalopathy - Amantadine HCl for hypoxic encephalopathy | JPRN-UMIN000003160 |
| Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia | A Double-blind, Randomized, Placebo-controlled Trial With Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia | NCT00999505 |
| Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) | Amantadine VS Ritalin in the Treatment of ADHD: a Double Blind Randomized Trial | NCT01099059 |
| A Randomized Open Label Study Comparing the Efficacy, Safety, and Tolerability of Oral Administration of Amantadine and Ribavirin with Oseltamivir Versus Oseltamivir to Influenza A Virus Infected Immunocompromised Subjects - TCAD Therapy for treatment of influenza A in immunocompromised subjects | A Randomized Open Label Study Comparing the Efficacy, Safety, and Tolerability of Oral Administration of Amantadine and Ribavirin with Oseltamivir Versus Oseltamivir to Influenza A Virus Infected Immunocompromised Subjects - TCAD Therapy for treatment of influenza A in immunocompromised subjects | EUCTR2009-015850-39-NL |
| Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation | Amantadine Addition to Paliperidone ER or Risperidone Consta Therapy for Prolactin Elevation | NCT00975611 |
| Pilot Study of Maintenance Therapy With Intravenous AMANTADINE | Maintenance Therapy of Intravenous Amantadine in Patients With Idiopathic Parkinson Disease Who Are Not Optimally Treated With Anti Parkinson Medications | NCT01190553 |
| Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications | A Randomized Double-Blind Phase 2 Study Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications | NCT01227967 |
| The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy | A Double Blind, Placebo-controlled Study for the Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy | NCT01313819 |
| Effect of Intravenous Amantadine on Gait Freezing in Parkinson's Disease | Randomized Double-blind Placebo-controlled Trial of Intravenous Amantadine on Gait Freezing in Patients With Parkinson's Disease | NCT01313845 |
| Influence of high dose intraoperative remifentanil with or without amantadine on postoperative pain intensity and morphine consumption in major abdominal surgery patients | Influence of high dose intraoperative remifentanil with or without amantadine on postoperative pain intensity and morphine consumption in major abdominal surgery patients | DRKS00004626 |
| Amantadine in the treatment of autism | A double - blind placebo controlled traial of Amantadine added to risperidone in patint with autistic disorder | IRCT201106101556N25 |
| Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects | A Randomized Open Label Study Comparing the Efficacy, Safety and Tolerability of Oral Administration of Amantadine and Ribavirin and Oseltamivir Versus Oseltamivir to Influenza A Virus Infected Immunocompromised Subjects. | ACTRN12609000708257 |
| A Phase IIa, Double-Blind, Placebo-Controlled, Randomised, Fourfold Cross-Over Study to Investigate the Glucose Lowering Effects of Dextromethorphan and Amantadine in Subjects with Type 2 Diabetes Mellitus (T2DM) after an Oral Glucose Tolerance Test | A Phase IIa, Double-Blind, Placebo-Controlled, Randomised, Fourfold Cross-Over Study to Investigate the Glucose Lowering Effects of Dextromethorphan and Amantadine in Subjects with Type 2 Diabetes Mellitus (T2DM) after an Oral Glucose Tolerance Test | EUCTR2011-002986-39-DE |
| Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease | Efficacy of Amantadine for Gait Dysfunction and Gait Freezing in Patients With Parkinson's Disease | NCT01652534 |
| Effectiveness of Amantadine Hydrochloride for Treatment of Severe Traumatic Brain Injury (TBI) | A Multicenter Prospective Randomized Controlled Trial of the Effectiveness of Amantadine Hydrochloride in Promoting Recovery of Function Following Severe Traumatic Brain Injury | NCT00970944 |
| Dextromethorphan, Amantadine and Glucose Homeostasis in Diabetes Subjects | A Phase IIa, Double-blind, Placebo-controlled, Randomised, Fourfold Crossover Study to Investigate the Glucose Lowering Effects of Dextromethorphan and Amantadine in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test | NCT01441986 |
| Effect of co-administration of Amantadine and Aspirin on fatigue in patients with multiple sclerosis | Therapeutic effect of co-administration of Amantadine and Aspirin on fatigue in patients with multiple sclerosis: a randomized placebo-controlled double-blind study | IRCT201112208430N3 |
| Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease | Impact of Amantadine on L-DOPA-induced Dyskinesia in Early Parkinson's Disease: a Placebo-controlled Randomized Study (the PREMANDYSK Study) | NCT01538329 |
| STUDY OF EFFECTIVENESS, TOLERABILITY AND SAFETY OF THERAPY WITH AMANTADINE IN DEGENERATIVE ATAXIAS | RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, STUDY OF EFFECTIVENESS, TOLERABILITY AND SAFETY OF THERAPY WITH AMANTADINE IN DEGENERATIVE ATAXIAS | EUCTR2012-003315-63-ES |
| Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) | Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study) | NCT01397422 |
| Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection | Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection | NCT00830323 |
| Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease | Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease | NCT01789047 |
| Effect of amantadine on methamphetamine-withdrawal induced fatigue | Effect of amantadine on controlling methamphetamine-withdrawal induced fatigue (double-blind, controlled clinical trial) | IRCT2015111524853N2 |
| Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot Study | Mechanism of Amantadine and Functional Improvement Following Acquired Brain Injury as Measured by MRI Tractography; A Pilot Study | NCT02566720 |
| The Effect of Amantadine As Add-on Therapy for Motor Fluctuations in Advanced Parkinson's Disease: a Randomized Double-blinded Placebo-controlled Trial | The Effect of Amantadine As Add-on Therapy for Motor Fluctuations in Advanced Parkinson's Disease: a Randomized Double-blinded Placebo-controlled Trial | NCT06817200 |
| The Clinical Efficacy of Amantadine on Vegetative State Post-Traumatic Brain Injury | The Clinical Efficacy of Amantadine on Vegetative State Post-Traumatic Brain Injury | ChiCTR2400091956 |
| AMANTADINE AND TRANSCRANIAL MAGNETIC TRANSCRANIAL MAGNETIC STIMULATION FOR FATIGUE IN MULTIPLE SCLEROSIS: A PHASE III, CONTROLLED, RANDOMISED, DOUBLE-BLIND, CROSSOVER TRIAL | AMANTADINE AND TRANSCRANIAL MAGNETIC TRANSCRANIAL MAGNETIC STIMULATION FOR FATIGUE IN MULTIPLE SCLEROSIS: A PHASE III, CONTROLLED, RANDOMISED, DOUBLE-BLIND, CROSSOVER TRIAL - FETEM | CTIS2024-516732-97-00 |
| Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness | Effects of Intravenous Amantadine Sulphate on Brain Dynamics and Neurobehavioral Status in Patients With Disorders of Consciousness | NCT06443827 |
| Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI). | Multicenter, Double-blind, Randomized, Placebo Controlled, Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301), in Patients With Severe Traumatic Brain Injury (TBI). | NCT06253923 |
| A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid | Feasibility Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid: A Pilot Randomized Control Trial | NCT06234462 |
| Amantadine in cancer fatigue | Evaluation of Amantadine efficacy compared to placebo in the treatment of cancer-related fatigue: a randomized, double-blind clinical trial. | IRCT20181208041882N10 |
| Amantadine Therapy for Cognitive Impairment in Long COVID | Amantadine Therapy for Cognitive Impairment Related to Post-COVID Condition | NCT06055244 |
| Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU | The Impact and Outcomes of Combined Cerebrolysin and Amantadine Sulfate Administration on Management of Patients With Traumatic Brain Injury in the ICU | NCT06052787 |
| The effect of amantadine on the recovery of patients with traumatic brain injury | The effect of amantadine on the recovery of patients with severe brain injury: a randomized controlled clinical trial | IRCT20190618043934N18 |
| Palliative pharmacotherapy for cancer-related fatigue | Efficacy of palliative pharmacotherapy with Methylphenidate, Bupropion, Ginseng, and Amantadine to improve fatigue in people with advanced cancer (5-EPIFAT) | IRCT20150302021307N6 |
| Safety and Efficacy of Amantadine Tablets for the Treatment of Parkinsons Disease (A disorder of the central nervous system that affects movement, often including tremors) and Drug-induced Extrapyramidal Reactions (involuntary or uncontrollable movements, tremors, muscle contractions) in Patients | A Prospective, Multi-centre, Single-arm, Phase IV Study to Assess the Safety and Efficacy of Amantadine Extended Release Tablets for the Treatment of Parkinsons Disease and Drug-induced Extrapyramidal Reactions in Adult Patients | CTRI/2023/04/051973 |
| Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis | Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis: Phase III Study, Controlled, Randomized, Crossed Over and Double Blind. | NCT05809414 |
| Brazilian trial of Amantadine for disorders of consciousness after intracranial bleeding due to aneurysm rupture | Amantadine for disorders of consciousness after Aneurysmal Subarachnoid Hemorrhage | RBR-6789t4v |
| The Effect of Amantadine on Post-COVD-19 Fatigue | The Effect of Amantadine on Post-COVD-19 Fatigue: a Clinical Trial | NCT05667077 |
| Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection | Evaluation of Treatments With Antihistamines and Amantadine in the Evolution of the SARS-CoV-2 Infection | NCT05504057 |
| AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES) | AmaNtadine for NeuroenhancEment in acutE patients Study - A prospective pilot proof of concept phase IIb study in intensive and intermediate care unit patients (ANNES) | EUCTR2022-002418-18-DE |
| Amantadine for Neuroenhancement in Acute Patients Study | Amantadine for Neuroenhancement in Acute Patients Study - A Prospective Pilot Proof of Concept Phase IIb Study in Intensive and Intermediate Care Unit Patients | NCT05479032 |
| Effect of acupuncture in relieving fatigue of multiple sclerosis | Comparison study between the effect of amantadine and acupuncture in relieving fatigue in multiple sclerosis patients (randomized controlled trial) | IRCT20210718051931N1 |
| Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease | Quantification of the Antidyskinetic Effect of Amantadine and Topiramate in Parkinson's Disease | NCT00794313 |
| Add on amantadine for sub acute sclerosing panencephalitis in children and adolescents | Evaluation of efficacy of add on oral amantadine in children and adolescents with subacute sclerosing panencephalitis aged less than 18years: A randomized controlled trial - nil | CTRI/2025/04/085165 |
| Amantadine in bipolar depression | Evaluating effect of Amantadine adjuvant therapy on depression index of bipolar patients | IRCT20100127003210N32 |
| Bioequivalence study of Amantadine 100 mg capsule | In vivo bioequivalence study of Amantadine 100 mg capsule manufactured by Aani Darman Co. compared with innovator product | IRCT20210519051345N82 |
| A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease | Comparative Efficacy and Safety of Propranolol Versus Amantadine in Controlling Tremors in Parkinson's Disease: A Randomized Controlled Trial | NCT07113015 |
| Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine | Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine | NCT00600093 |
| Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability | Utility of Amantadine Hydrochloride in the Treatment of Post-traumatic Irritability: A Randomized, Double-Blind, Placebo-Controlled Trial | NCT00627250 |
| Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State | Amantadine Hydrochloride for Treatment of Symptoms of the Post-traumatic Confusional State Among Neurorehabilitation Admissions With TBI: A Randomized, Double-Blind, Placebo-Controlled Trial | NCT00693121 |
| A randomized, double-blind, placebo-controlled, cross-over, multi-center study concerning the efficacy and safety of amantadine hydrochloride in treatment of dyskinesias in Parkinson's disease | A randomized, double-blind, placebo-controlled, cross-over, multi-center study concerning the efficacy and safety of amantadine hydrochloride in treatment of dyskinesias in Parkinson's disease - The usefulness of amantadine hydrochloride in treatment of dyskinesias in Parkinson's disease | JPRN-UMIN000000780 |
| Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine | An Open-Label, Multiple Dose, Randomized, Three-Period Crossover Study in Healthy Volunteers to Evaluate the Effect of co-Administration of Amantadine 100 mg BID and Oseltamivir 75 mg BID on the Pharmacokinetic Properties of Amantadine and Oseltamivir. | NCT00416962 |
| Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine | The Assessment of the Safety, Efficacy, and Practicality of an Algorithm Including Amantadine, Metformin and Zonisamide for the Prevention of Olanzapine-Associated Weight Gain in Outpatients With Schizophrenia | NCT00401973 |
| Retreatment of chronic hepatitis C patients with pegylated interferon (IFN), ribavirin and amantadine; a pilot study to establish if initial drop in viral load is predictive for sustained virological response | Retreatment of chronic hepatitis C patients with pegylated interferon (IFN), ribavirin and amantadine; a pilot study to establish if initial drop in viral load is predictive for sustained virological response | ISRCTN81536220 |
| Study of Amantadine for Weight Stabilization During Olanzapine Treatment | Double Blind Placebo Controlled Investigation of Amantadine for Retarding Weight Gain in First Episode Adlt Psychotic Subjects Beginning Therapy With Olanzapine. | NCT00287352 |
| Retreatment of chronic hepatitis C patients with pegylated interferon, ribavirin and amantadine; A pilot study to establishif initial drop in viral load is predictive for sustained virological response. | Retreatment of chronic hepatitis C patients with pegylated interferon, ribavirin and amantadine; A pilot study to establishif initial drop in viral load is predictive for sustained virological response. | NL-OMON27702 |
| Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients | Randomized Placebo-Controlled Trial of a Triple Therapy Combining Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine Versus Peginterferon Alfa-2a Plus Ribavirin Plus Placebo in Hepatitis C-Infected Patients Non Responders to a First-Line Therapy of Interferon and Ribavirin | NCT00221624 |
| Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI) | Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury | NCT00800514 |
| Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2 | A Double-Blind, Placebo Controlled Trial of Propranolol and Amantadine for the Treatment of Cocaine Dependent Subjects With Severe Cocaine Withdrawal Symptoms | NCT00158132 |
| Study on chronic hepatitis Ctreatment with interferon alpha, ribavirin and amantadine in naive patients. | Study on chronic hepatitis Ctreatment with interferon alpha, ribavirin and amantadine in naive patients. | NL-OMON20761 |
| Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) | Randomized, Multi-Center, Partially Placebo-Controlled Phase IV-Study to Compare Efficacy and Tolerability of 48-Week Combined Therapy With Peginterferon Alfa-2a, Ribavirin and Amantadine Sulphate Versus Placebo in Untreated Patients With Chronic Hepatitis C Virus-Genotype-1-Infection | NCT00127777 |
| Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) | Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) | NCT00127114 |
| Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders | Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous HCV Non Responders ANRSHC03 BITRI | NCT00122629 |
| Treatment of Huntington's Chorea With Amantadine | NMDA-Receptor Blockade in Huntington's Chorea | NCT00001930 |
| Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4 | Rapid Evaluation of Cocaine Pharmacotherapies (Amantadine) | NCT00000301 |
| COMBINA. Efficacité et tolérance des bithérapies oseltamivir + zanamivir ou oseltamivir + amantadine en comparaison avec la monothérapie oseltamivir dans le traitement de la grippe saisonnière A - COMBINA | COMBINA. Efficacité et tolérance des bithérapies oseltamivir + zanamivir ou oseltamivir + amantadine en comparaison avec la monothérapie oseltamivir dans le traitement de la grippe saisonnière A - COMBINA | EUCTR2008-004543-11-FR |
| Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome | The Effect of Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome; Randomized Controlled Study | NCT07421427 |
| The effect of amantadine on cognitive dysfunction and quality of life in adults with traumatic brain injury. | Investigating the effectiveness of amantadine in improving cognitive dysfunction and improving quality of life in adults with moderate traumatic brain injur | IRCT20151123025202N50 |
| Intervention of early use of amantadine on the outcome of patients with diquat poisoning | Intervention of early use of amantadine on the outcome of patients with diquat poisoning | ChiCTR2500109316 |
| Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients | Study on Chronic Hepatitis C Treatment With Interferon Alpha, Ribavirin and Amantadine in Naive Patients | NCT00146016 |
| Amantadine in methamphetamine-dependent patients | The assessment of amantadine add-on therapy effects on craving and relapse reduction among patients with methamphetamine dependence. | IRCT20090801002266N16 |
| Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain Syndrome | Effectiveness of Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain Syndrome; Randomized Controlled Study | NCT06833203 |
| Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression | Comparative Efficacy of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment-resistant Unipolar Depression: A Randomized Controlled Trial. | NCT04936126 |
| The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms | The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms in Patients Infected With the SARS-CoV-2 Virus | NCT04854759 |
| The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus | The use of amantadine in the prevention of progression and treatment of COVID-19 symptoms in patients infected with the SARS-CoV-2 virus - COV-PREVENT | EUCTR2021-001144-98-PL |
| Efficacy of Add-on Amantadine to clonidine on severity of opioid withdrawal symptoms. | Evaluation the efficacy of Add-on Amantadine to clonidine on severity of opioid withdrawal symptoms. | IRCT20090801002266N15 |
| An effectiveness and safety comparison study of N-acetylcysteine and amantadine on fatigue and Disability and quality of life of multiple sclerotic patients | Clinical trial comparing the efficacy and safety of N-acetylcysteine and amantadine on fatigue and disability and quality of life of patients with MS | IRCT20201216049736N1 |
| efficacy of amantadine vs Ropinirole in Restless legs syndrome | Comparison of Amantadine vs. Ropinirole in Restless legs syndrome: A single blind Randomized Controlled exploratory trial | CTRI/2020/11/029296 |
| Promoting Recovery After STroke with Amantadine | Promoting Recovery After STroke with Amantadine | NCT05140148 |
| Amantadine Sulphate versus magnesium sulfate on Traumatic Brain Injury. | Comparative Study between the Efficacy of Amantadine Sulphate versus magnesium sulfate on Traumatic Brain Injury. A prospective randomized trial | PACTR202009761063655 |
| Impact of Amantadine on Traumatic Brain Injury | Potential Impact of Amantadine on Traumatic Brain Injury Outcomes | NCT04527289 |
| Evaluation of the Effect of Preoperative Intravenous Amantadine Sulfate on the Postoperative Early Cognitive Functions in a Elderly Patient With Laparoscopic Radical Prostatectomy | Evaluation of the Effect of Preoperative Intravenous Amantadine Sulfate on the Postoperative Early Cognitive Functions in a Elderly Patient With Laparoscopic Radical Prostatectomy | NCT03988010 |
| AMANTADINE AND TRANSCRANIAL MAGNETIC STIMULATION FOR TREATING FATIGUE IN MULTIPLE SCLEROSIS | AMANTADINE AND TRANSCRANIAL MAGNETIC STIMULATION FOR TREATING FATIGUE IN MULTIPLE SCLEROSIS: PHASE III STUDY, CONTROLLED, RANDOMIZED, CROSSED OVER AND DOUBLE BLIND - FETEM | EUCTR2021-004868-95-ES |
| Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma | Acetyl-Amantadine as a Biomarker in Patients With Glioblastoma | NCT04530006 |
| Amantadine and dalfampiridine effects on multiple sclerosis | Comparison of amantadine and dalfampridine efficacy in multiple sclerosis patients with fatigue | IRCT20190804044429N2 |
| Effectiveness of Yoga Comparing to Amantadine and Commitment Group Therapy in Patients with Multiple Sclerosis | Effectiveness of Yoga Comparing to Amantadine and Commitment Group Therapy on Fatigue and Pain and Life Quality in Patients with Multiple Sclerosis | IRCT20200423047176N1 |
| Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy | Use of Amantadine in Treating Cognitive and Motor Impairments in Adolescents and Adults With Cerebral Palsy | NCT04273737 |
| Treatment of mild COVID-19: a randomized, double blinded, placebo controlled study | Amantadine for COVID-19: A randomized, placebo controlled, double-blinded, clinical trial | EUCTR2021-001177-22-DK |
| effectivness of amantadine hydrocholoride on functional recovery in sever traumatic brain injery | effectivness of amantadine hydrocholoride on functional recovery in sever traumatic brain injery | IRCT20120527009878N7 |
| Oral Amantadine, IV Amantadine and Hemodynamic Response to Laryngoscopy | Oral Amantadine Versus IV Amantadine to Attenuate the Hemodynamic Response to Laryngoscopy, Tracheal Intubation and Surgical Incision and Their Effect on ß-endorphin: A Randomized Clinical Trial | NCT03612921 |
| Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation | Oral Amantadine Versus Gabapentin to Attenuate the Hemodynamic Response to Laryngoscopy and Tracheal Intubation and Their Effect on ß-endorphin | NCT03172234 |
| Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients | The Implications of Amantadine Sulphate Usage in Spine Deformities Corrective Surgeries Patients as Regard Its Effect on the Duration of Wake up Test and Postoperative Opioid Consumption | NCT03178708 |
| Bupropion and amantadine in sexual function in patients with methadone | Comparison the effect of Bupropion and Amantadine in reducing sexual dysfunction in patients taking methadone | IRCT20170606034348N5 |
| Effects of Ondansetron versus Amantadine on fatigability in patients with multiple sclerosis | Effects of Ondansetron versus Amantadine on fatigability in patients with multiple sclerosis: a randomized clinical trial | IRCT20120215009014N250 |
| The effect of zolpidem and amantadine on the level of consciousness in patients diffuse axonal injury | The effect of zolpidem and amantadine on the level of consciousness in patients diffuse axonal injury | IRCT20191026045243N1 |
| Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine | A Randomized, Double-blind, Placebo-controlled, Multi-center Clinical Study of Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine | NCT04173832 |
| Concomitant Administration of the Methylphenidate and Amantadine | Evaluating the Effect of the Concomitant Administration of Methylphenidate and Amantadine on the TBI-related Outcomes: A Randomized, Double-blind, Placebo-controlled, Parallel trial | IRCT20130310012776N7 |
| Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis | Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis | NCT03185065 |
| Citicholine-Amantadine Trial in Traumatic Brain Injury | Citicholine-Amantadine Trial in Traumatic Brain Injury | NCT03430817 |
| Benefits of Amantadine in Patients With Coma State | | NCT03443037 |
| Effects of Amantadine on Postoperative Cognitive Dysfunction | Effects of Amantadine on Postoperative Cognitive Dysfunction in Elderly Patients With Elective Abdominal Surgery | NCT03527134 |
| Is Long-term Use of Amantadine Effective in PD? | Is Long-term Use of Amantadine Effective in Parkinson Disease? | NCT04260581 |
